Zhang Hui-dan, Chen Hui-chi, Shan Lian-feng
Department of Cell Biology, China Medical University, Shenyang 110001, China.
Zhonghua Fu Chan Ke Za Zhi. 2006 Jan;41(1):7-11.
To determine the relationships between maternal serum copper, amniotic copper, lysyl oxidase (LOX) and collagen III in pregnant women with premature rupture of membranes (PROM) and without PROM.
One hundred women with PROM were enrolled in this study, and divided into 37-42 weeks, 34-36(+6) weeks and 28-33(+6) weeks according to gestational age. One hundred non-PROM pregnancies matching the same gestational ages were recruited as control group. Copper of maternal serum and amnion in two groups were compared by FAAS method. Amniotic LOX was analyzed by fluorometry. Amniotic collagen III was detected by immunohistochemical method and computer image analysis system (absorbance, A). Linear correlation analysis was used to explore the relationships between maternal serum copper, amniotic copper, LOX and collagen III.
(1) For 37-42 weeks pregnant women, serum copper was correlated positively with amniotic copper in two groups, r = 0.82 (P < 0.001), but for other parameters, the serum and amniotic levels had no correlations. (2) For 34-36(+6) and 28 - 33(+6) weeks pregnant women, there were positive correlations between serum copper, amniotic copper, LOX and collagen III in two groups (P < 0.01). (3) For 37-42 weeks pregnant women, serum copper and amniotic copper had no difference between two groups (P > 0.05), but amniotic LOX and collagen III decreased significantly compared with controls, being [(0.53 +/- 0.10) microg/g vs (0.75 +/- 0.10) microg/g, P < 0.01], (0.36 +/- 0.01 vs 0.37 +/- 0.01, P < 0.05) respectively. (4) For 34 - 36(+6) weeks pregnant women, serum copper, amniotic copper, LOX and collagen III reduced obviously between two groups (P < 0.01), being respectively [(115.23 +/- 9.56) mg/L vs (139.03 +/- 10.59) mg/L], [(0.21 +/- 0.04) microg/mg vs (0.29 +/- 0.04) microg/mg], [(0.54 +/- 0.10) microg/g vs (0.70 +/- 0.13) microg/g], and (0.36 +/- 0.01 vs 0.37 +/- 0.01). (5) For 28-33(+6) weeks pregnant women, serum copper, amniotic copper, LOX and collagen III also reduced obviously between two groups (P < 0.01), [(120.31 +/- 8.04) microg/L vs (136.40 +/- 8.21) microg/L], [(0.21 +/- 0.04) microg/mg vs (0.26 +/- 0.03) microg/mg], [(0.62 +/- 0.09) microg/g vs (0.72 +/- 0.09) microg/g], and (0.35 +/- 0.01 vs 0.38 +/- 0.01).
For term pregnant women, the decreases of amniotic LOX and collagen III in PROM group are not affected by serum copper, perhaps by excessive degeneration of amnion; for non-term pregnant women, the decreases of serum copper, amniotic copper, LOX and collagen III are correlated directly with PROM.
确定胎膜早破(PROM)孕妇和无胎膜早破孕妇的母血铜、羊水铜、赖氨酰氧化酶(LOX)和Ⅲ型胶原之间的关系。
本研究纳入100例胎膜早破孕妇,根据孕周分为37 - 42周、34 - 36(+6)周和28 - 33(+6)周三组。选取100例相同孕周的未发生胎膜早破的孕妇作为对照组。采用火焰原子吸收光谱法(FAAS)比较两组孕妇母血和羊水中的铜含量。用荧光分析法分析羊水LOX。采用免疫组织化学方法和计算机图像分析系统(吸光度,A)检测羊水Ⅲ型胶原。采用线性相关分析探讨母血铜、羊水铜、LOX和Ⅲ型胶原之间的关系。
(1)对于37 - 42周的孕妇,两组母血铜与羊水铜呈正相关,r = 0.82(P < 0.001),但其他参数的母血和羊水水平无相关性。(2)对于34 - 36(+6)周和28 - 33(+6)周的孕妇,两组母血铜、羊水铜、LOX和Ⅲ型胶原之间均呈正相关(P < 0.01)。((3)对于37 - 42周的孕妇,两组母血铜和羊水铜无差异(P > 0.05),但羊水LOX和Ⅲ型胶原较对照组显著降低,分别为[(0.53 ± 0.10)μg/g对(0.75 ± 0.1)μg/g,P < 0.01],(0.36 ± 0.01对0.37 ± 0.01,P < 0.05)。(4)对于34 - 36(+6)周的孕妇,两组母血铜羊水铜、LOX和Ⅲ型胶原均明显降低(P < 0.01),分别为[(115.23 ± 9.56)mg/L对(139.03 ± 10.59)mg/L],[(0.21 ± 0.04)μg/mg对(0.29 ± 0.04)μg/mg],[(0.54 ± 0.10)μg/g对(0.70 ± 0.13)μg/g],以及(0.36 ± 0.01对0.37 ± 0.01)。(5)对于28 - 33(+6)周的孕妇,两组母血铜、羊水铜、LOX和Ⅲ型胶原也明显降低(P < 0.01),分别为[(120.31 ± 8.04)μg/L对(136.40 ± 8.21)μg/L],[(0.21 ± 0.04)μg/mg对(0.26 ± 0.03)μg/mg],[(0.62 ± 0.09)μg/g对(0.72 ± 0.09)μg/g],以及(0.35 ± 0.01对0.38 ± 0.01)。
对于足月孕妇,胎膜早破组羊水LOX和Ⅲ型胶原的降低不受母血铜影响,可能与羊膜过度退变有关;对于未足月孕妇,母血铜、羊水铜、LOX和Ⅲ型胶原的降低与胎膜早破直接相关。